Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

ERK2 anticorps (pThr185, pTyr187)

MAPK1 Reactivité: Humain WB, IHC (p), ICC Hôte: Souris Monoclonal MAPK-YT unconjugated
N° du produit ABIN533235
  • Antigène Voir toutes ERK2 (MAPK1) Anticorps
    ERK2 (MAPK1) (Mitogen-Activated Protein Kinase 1 (MAPK1))
    Épitope
    • 16
    • 11
    • 9
    • 8
    • 7
    • 6
    • 6
    • 5
    • 5
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    pThr185, pTyr187
    Reactivité
    • 134
    • 73
    • 69
    • 14
    • 9
    • 7
    • 7
    • 6
    • 5
    • 5
    • 5
    • 4
    • 3
    • 2
    • 2
    • 1
    Humain
    Hôte
    • 98
    • 34
    • 4
    • 3
    • 1
    Souris
    Clonalité
    • 89
    • 52
    Monoclonal
    Conjugué
    • 88
    • 11
    • 9
    • 5
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    Cet anticorp ERK2 est non-conjugé
    Application
    • 101
    • 65
    • 41
    • 30
    • 24
    • 23
    • 14
    • 8
    • 6
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunocytochemistry (ICC)
    Fonction
    Mouse monoclonal antibody raised against synthetic phosphopeptide of MAPK1.
     Réactivité croisée
    Humain, Souris, Rat, Saccharomyces cerevisiae
    Immunogène
    Synthetic phosphopeptide corresponding to residues surrounding T185/Y187 of human MAPK1.
    Clone
    MAPK-YT
    Isotype
    IgG1
    Top Product
    Discover our top product MAPK1 Anticorps primaire
  • Indications d'application
    Western Blot (0.25-0.5 μg/mL)
    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (0.4-1 μg/mL)
    The optimal working dilution should be determined by the end user.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Buffer
    Lyophilized from 1.2 % sodium acetate (2 mg BSA, 0.01 mg sodium azide)
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C
    Stockage commentaire
    Store at -20°C on dry atmosphere.
    After reconstitution with 1 mL of 1.2% sodium acetate or neutral PBS and concentration will be 100 ug/mL, store at -20°C or lower.
    Aliquot to avoid repeated freezing and thawing.
  • Scholl, Dumesic, Barragan, Harada, Bissonauth, Charron, Khavari: "Mek1/2 MAPK kinases are essential for Mammalian development, homeostasis, and Raf-induced hyperplasia." dans: Developmental cell, Vol. 12, Issue 4, pp. 615-29, (2007) (PubMed).

    Rodriguez-Viciana, Tetsu, Tidyman, Estep, Conger, Cruz, McCormick, Rauen: "Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome." dans: Science (New York, N.Y.), Vol. 311, Issue 5765, pp. 1287-90, (2006) (PubMed).

  • Antigène
    ERK2 (MAPK1) (Mitogen-Activated Protein Kinase 1 (MAPK1))
    Autre désignation
    ERK2 (MAPK1 Produits)
    Synonymes
    anticorps ERK-1, anticorps ERK1, anticorps ERT2, anticorps HS44KDAP, anticorps HUMKER1A, anticorps P44ERK1, anticorps P44MAPK, anticorps PRKM3, anticorps p44-ERK1, anticorps p44-MAPK, anticorps Erk-1, anticorps Erk1, anticorps Ert2, anticorps Esrk1, anticorps Mnk1, anticorps Mtap2k, anticorps Prkm3, anticorps p44, anticorps p44erk1, anticorps p44mapk, anticorps ERK, anticorps ERK2, anticorps ERT1, anticorps MAPK2, anticorps P42MAPK, anticorps PRKM1, anticorps PRKM2, anticorps p38, anticorps p40, anticorps p41, anticorps p41mapk, anticorps 9030612K14Rik, anticorps AA407128, anticorps AU018647, anticorps C78273, anticorps Erk2, anticorps Prkm1, anticorps p42mapk, anticorps zERK2, anticorps MAPK1, anticorps Xp42, anticorps erk, anticorps erk2, anticorps ert1, anticorps mapk, anticorps mapk1b, anticorps mapk2, anticorps mpk1, anticorps prkm1, anticorps prkm2, anticorps mapk1, anticorps mapk1a, anticorps xp42, anticorps ATMPK1, anticorps F14N23.9, anticorps F14N23_9, anticorps MITOGEN-ACTIVATED PROTEIN KINASE, anticorps mitogen-activated protein kinase 1, anticorps MNK1, anticorps ATMPK2, anticorps MITOGEN-ACTIVATED PROTEIN KINASE HOMOLOG 2, anticorps T30E16.13, anticorps T30E16_13, anticorps mitogen-activated protein kinase homolog 2, anticorps mitogen-activated protein kinase 3, anticorps mitogen-activated protein kinase 1, anticorps mitogen activated protein kinase 1, anticorps mitogen-activated protein kinase 1 L homeolog, anticorps mitogen-activated protein kinase 1 S homeolog, anticorps mitogen activated protein kinase 3, anticorps mitogen-activated protein kinase homolog 2, anticorps MAPK3, anticorps Mapk3, anticorps MAPK1, anticorps Mapk1, anticorps mapk1, anticorps mapk1.L, anticorps mapk1.S, anticorps PfMAP1, anticorps MPK1, anticorps PVX_084965, anticorps LOC9328617, anticorps Tsp_01601, anticorps MPK2
    ID gène
    5594
    Pathways
    Signalisation MAPK, Signalisation RTK, Apoptose, Interferon-gamma Pathway, Fc-epsilon Receptor Signaling Pathway, Response to Growth Hormone Stimulus, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Hepatitis C, Protein targeting to Nucleus, Toll-Like Receptors Cascades, Monocarboxylic Acid Catabolic Process, Autophagy, G-protein mediated Events, Signaling Events mediated by VEGFR1 and VEGFR2, Signaling of Hepatocyte Growth Factor Receptor, VEGFR1 Specific Signals, BCR Signaling, S100 Proteins
Vous êtes ici:
Support technique